Overall, the data indicate that in HR-positive breast cancer, hormonal regulation on CCL2 expression might be strongly related to modulation of Twist expression via PI3K/AKT/NF-κB signaling instead of MEK/ERK pathway. This evidence concerns the gene CCL2 and breast carcinoma.